Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Capital Analysts
Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Capital Analysts
from 13F filings
Historical chart of Capital Analysts investment in Neurocrine Biosciences Inc Note 2.250 5/1
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Capital Analysts
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $4.0k | 2.0k | 2.00 |
2023-12-31 | $3.0k | 2.0k | 1.50 |
2023-09-30 | $3.0k | 2.0k | 1.50 |
2023-06-30 | $3.0k | 2.0k | 1.50 |
2023-03-31 | $3.0k | 2.0k | 1.50 |
2022-12-31 | $3.0k | 2.0k | 1.50 |
2022-09-30 | $3.0k | 2.0k | 1.50 |
2022-06-30 | $3.0k | 2.0k | 1.50 |
2022-03-31 | $3.0k | 2.0k | 1.50 |
2021-12-31 | $2.0k | 2.0k | 1.00 |
2021-09-30 | $3.0k | 2.0k | 1.50 |
2021-06-30 | $3.0k | 2.0k | 1.50 |
2021-03-31 | $3.0k | 2.0k | 1.50 |
2020-12-31 | $3.0k | 2.0k | 1.50 |
2020-09-30 | $3.0k | 2.0k | 1.50 |
2020-06-30 | $3.0k | 2.0k | 1.50 |
2020-03-31 | $3.0k | 2.0k | 1.50 |
2019-12-31 | $3.0k | 2.0k | 1.50 |
2019-09-30 | $2.0k | 2.0k | 1.00 |
2019-06-30 | $3.0k | 2.0k | 1.50 |
2019-03-31 | $2.0k | 2.0k | 1.00 |
2018-12-31 | $2.0k | 2.0k | 1.00 |
2018-09-30 | $3.4k | 2.0k | 1.70 |
Top funds holding Neurocrine Biosciences Inc Note 2.250 5/1
View all funds holding Neurocrine Biosciences Inc Note 2.250 5/1